1 May 2026Oral drugsSource update: January 2024
Lactulose oral
Lactulose guidance for prevention of constipation in patients taking opioid analgesics, with stool-response monitoring.
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.
Therapeutic action
Osmotic laxative.
Indications
Prevention of constipation in patients taking opioid analgesics such as codeine and morphine.
Forms and strengths
- 10 g/15 ml oral solution, to be administered using a measuring device.
Dose and duration
Start lactulose when analgesic treatment continues more than 48 hours.
Lactulose must be taken daily until the end of the opioid treatment. Regular follow up of stool frequency and consistency is essential in order to adjust dosage correctly.
- Child under 1 year: 5 ml daily (3.3 g daily).
- Child from 1 to 6 years: 5 to 10 ml daily (3.3 to 6.7 g daily).
- Child from 7 to 14 years: 10 to 15 ml daily (6.7 to 10 g daily).
- Child over 14 years and adult: 15 to 45 ml daily (10 to 30 g daily).
Contra-indications, adverse effects, precautions
- Do not administer to patients with Crohn's disease, ulcerative colitis, intestinal obstruction, or undiagnosed abdominal pain.
- May cause abdominal discomfort, flatulence, and diarrhoea.
- In the event of diarrhoea, exclude faecal impaction and intestinal obstruction, then reduce the dose.
- Pregnancy: no contra-indication.
- Breast-feeding: no contra-indication.
Source
MSF Essential drugs practical guidelines (January 2026)
This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.
Rate this guide
Be the first to rate this guide.
